Markers of Brain Cell Damage Higher in Patients with COVID-19 than Alzheimer’s
NYU Langone Health
Higher levels of seven markers of brain damage in COVID-19 patients with neurological symptoms than those without them
Articles by NYU Langone Health
Progress in Xenotransplantation Opens Door to New Supply of Organs
NYU Langone Health
The first investigational transplantation of a nonhuman kidney to a human body was recently completed
Gene-Based Blood Test for Melanoma Spread Evaluates Treatment Progress
NYU Langone Health
The test monitors blood levels of DNA fragments released by dying tumor cells as an early indicator of treatment success
White Matter Lesion Mapping Tool Identifies Early Signs of Dementia
NYU Langone Health
The new tool can analyze tissue damage seen on MRI scans to detect early signs of cognitive decline
Telemedicine Transforms Response to COVID-19 in US Epicenter
NYU Langone Health
Study shows how virtual urgent care appointments increased by more than 600 percent, signaling a possible long-term shift in health care delivery
3D Genetic Structure in Blood Cancer Important Beyond DNA Code Changes
NYU Langone Health
A new study shows that whether T cell acute lymphoblastic leukemia worsens depends on structural changes in the layout of protein bundles called chromosomes